208111-98-2 Usage
Uses
Used in Pharmaceutical Research:
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one is used as a research compound for exploring its potential pharmaceutical applications due to its unique structural features and functional groups.
Used in Chemical Synthesis:
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one is used as an intermediate in the synthesis of more complex molecules, particularly in the fields of organic chemistry and materials science, where its specific structural elements can be utilized to create novel compounds with desired properties.
Used in Material Science:
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one is used as a component in the development of new materials, potentially for applications in areas such as coatings, adhesives, or polymers, where its chemical properties may contribute to improved performance.
Note: The specific uses mentioned above are hypothetical and are provided as examples of potential applications based on the compound's structural characteristics. Actual uses would require further research and development to validate their feasibility and effectiveness.
Check Digit Verification of cas no
The CAS Registry Mumber 208111-98-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,8,1,1 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 208111-98:
(8*2)+(7*0)+(6*8)+(5*1)+(4*1)+(3*1)+(2*9)+(1*8)=102
102 % 10 = 2
So 208111-98-2 is a valid CAS Registry Number.
InChI:InChI=1/C25H21F3O6/c26-25(27,28)16-7-4-8-18(11-16)32-14-17(29)9-10-19-20-12-23(30)33-22(20)13-21(19)34-24(31)15-5-2-1-3-6-15/h1-11,19-22H,12-14H2/b10-9+/t19-,20-,21-,22+/m1/s1
208111-98-2Relevant academic research and scientific papers
Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
-
Page/Page column 58, (2010/01/29)
The present invention relates to an improved process for the production of prostaglandins and prostaglandin analogs. In particular, this invention relates to the production of prostaglandins of the PGF2α-series, including latanoprost, travoprost, and bimatoprost, which are active pharmaceutical ingredients used for the reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension.
